These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors. Leopoldo M; Lacivita E; Colabufo NA; Niso M; Berardi F; Perrone R Bioorg Med Chem; 2007 Aug; 15(15):5316-21. PubMed ID: 17517509 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents. Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptors. Betti L; Zanelli M; Giannaccini G; Manetti F; Schenone S; Strappaghetti G Bioorg Med Chem; 2006 Apr; 14(8):2828-36. PubMed ID: 16376083 [TBL] [Abstract][Full Text] [Related]
32. Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: a new step towards the design of high-affinity 5-HT1A ligands. Dilly S; Graulich A; Liégeois JF Bioorg Med Chem Lett; 2010 Feb; 20(3):1118-23. PubMed ID: 20022748 [TBL] [Abstract][Full Text] [Related]
33. Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands. Glennon RA; Naiman NA; Lyon RA; Titeler M J Med Chem; 1988 Oct; 31(10):1968-71. PubMed ID: 3172131 [TBL] [Abstract][Full Text] [Related]
35. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 4. Chodkowski A; Wróbel MZ; Turło J; Kleps J; Siwek A; Nowak G; Belka M; Bączek T; Mazurek AP; Herold F Eur J Med Chem; 2015 Jan; 90():21-32. PubMed ID: 25461308 [TBL] [Abstract][Full Text] [Related]
36. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5. Gomółka A; Ciesielska A; Wróbel MZ; Chodkowski A; Kleps J; Dawidowski M; Siwek A; Wolak M; Stachowicz K; Sławińska A; Nowak G; Satała G; Bojarski AJ; Belka M; Ulenberg S; Bączek T; Skowronek P; Turło J; Herold F Eur J Med Chem; 2015 Jun; 98():221-36. PubMed ID: 26043160 [TBL] [Abstract][Full Text] [Related]
37. 3-(omega-Aminoalkyl)-5,5-dialkyl(or spirocycloalkyl-1',5-)hydantoins as new 5-HT1A and 5-HT2A receptor ligands. Byrtus H; Pawłowski M; Charakchieva-Minol S; Duszyńska B; Mokrosz MJ; Mokrosz JL; Zejc A Arch Pharm (Weinheim); 1996 Jun; 329(6):283-90. PubMed ID: 8767112 [TBL] [Abstract][Full Text] [Related]
38. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines. Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188 [TBL] [Abstract][Full Text] [Related]
39. Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2. Stroth N; Niso M; Colabufo NA; Perrone R; Svenningsson P; Lacivita E; Leopoldo M Bioorg Med Chem; 2015 Aug; 23(15):4824-4830. PubMed ID: 26081758 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT Ali W; Więcek M; Łażewska D; Kurczab R; Jastrzębska-Więsek M; Satała G; Kucwaj-Brysz K; Lubelska A; Głuch-Lutwin M; Mordyl B; Siwek A; Nasim MJ; Partyka A; Sudoł S; Latacz G; Wesołowska A; Kieć-Kononowicz K; Handzlik J Eur J Med Chem; 2019 Sep; 178():740-751. PubMed ID: 31229876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]